Given the variable metabolic dependencies and microenvironmental contexts of different cancers, PDK1’s prognostic significance likely hinges on the extent of glycolytic reliance, hypoxia, oncogenic drivers, and immune landscape—underscoring its potential as a context-dependent biomarker and therapeutic target in metabolically plastic tumors such as osteosarcoma. Here, PDK1 is linked to cancer.